LNs < 18 | 18 ≦ LNs < 25 | 25 ≦ LNs | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Overall survival | ||||||
With RT | 0.61 (0.45–0.81) | 0.001 | 0.70 (0.45–1.11) | 0.128 | 0.99 (0.76–1.28) | 0.931 |
Male | 0.88 (0.66–1.18) | 0.397 | 1.14 (0.69–1.87) | 0.606 | 1.06 (0.81–1.39) | 0.672 |
Age | 1.04 (1.03–1.05) | < 0.001 | 1.04 (1.02–1.06) | 0.001 | 1.01 (1.001–1.02) | 0.038 |
Pathological T classification: T2 | 1.70 (1.28–2.25) | < 0.001 | 1.88 (1.17–3.03) | 0.009 | 1.69 (1.30–2.20) | < 0.001 |
Differentiation: poorly | 1.10 (0.79–1.54) | 0.562 | 1.27 (0.77–2.10) | 0.357 | 1.20 (0.90–1.61) | 0.209 |
Site: oropharynx | 0.48 (0.33–0.69) | < 0.001 | 0.52 (0.29–0.93) | 0.028 | 0.33 (0.23–0.47) | < 0.001 |
Disease-specific survival | ||||||
With RT | 0.62 (0.41–0.93) | 0.020 | 1.06 (0.57–1.99) | 0.848 | 1.20 (0.86–1.67) | 0.297 |
Male | 0.76 (0.51–1.13) | 0.169 | 1.12 (0.58–2.19) | 0.732 | 0.97 (0.70–1.36) | 0.868 |
Age | 1.02 (1.01–1.04) | 0.011 | 1.03 (0.99–1.06) | 0.054 | 1.00 (0.98–1.01) | 0.696 |
Pathological T classification: T2 | 1.65 (1.11–2.46) | 0.013 | 2.01 (1.04–3.91) | 0.039 | 1.49 (1.07–2.08) | 0.017 |
Differentiation: poorly | 1.24 (0.79–1.96) | 0.353 | 1.71 (0.87–3.35) | 0.119 | 1.38 (0.97–1.98) | 0.077 |
Site: oropharynx | 0.37 (0.21–0.63) | < 0.001 | 0.17 (0.06–0.48) | 0.001 | 0.29 (0.19–0.46) | < 0.001 |